Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
NCT00483327
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Atypical Endometrial Hyperplasia
Endometrial Carcinoma
Interventions
DRUG:
Megestrol Acetate
Sponsor
NYU Langone Health